Oncology PracticeAnother study supports safety of 2-cm margins for thick melanomasJuly 11, 2019Melanoma
Oncology PracticeNovel immune checkpoint holds ‘great promise’ as melanoma treatment targetJune 25, 2019MelanomaImmunotherapy
Oncology PracticeEntrectinib exhibits activity in children with solid tumorsMay 23, 2019CNS/Brain CancerPediatricsMelanomaSarcoma & GISTPediatric Neuroblastoma
Hospital Physician: Hematology/OncologyAdvanced Melanoma: Treatment After Progression on First-line Therapy May 23, 2019MelanomaGI OncologyImmunotherapy
Hospital Physician: Hematology/OncologyAdvanced Melanoma: First-line TherapyMay 17, 2019MelanomaImmunotherapy
Oncology PracticeENCORE-601: Entinostat/pembrolizumab safe, active for melanomaApril 18, 2019MelanomaImmuno-oncology
Oncology PracticeNovel immunostimulant combo shows early efficacyMarch 12, 2019MelanomaImmuno-oncologyBreast CancerSarcoma & GIST
Oncology PracticeAntibiotics gut checkpoint inhibitor efficacyMarch 12, 2019Immuno-oncologyHead & Neck/Thyroid CancersLung CancerMelanoma
Oncology Practice31-GEP test predicts likelihood of metastasis for cutaneous melanomaMarch 5, 2019Melanoma
Oncology PracticeDiet appears to play an important role in response to anti-PD-1 cancer immunotherapyMarch 1, 2019Immuno-oncologyMelanomaPatient & Survivor Care
Oncology PracticeFDA approves pembrolizumab for completely resected melanomaFebruary 19, 2019MelanomaImmuno-oncology
Oncology PracticeCheckpoint inhibitors ‘viable treatment option’ in HIV-infected individualsFebruary 8, 2019Immuno-oncologyLung CancerSarcoma & GISTMelanoma
